10D
10D is a venture capital firm that seeks to invest in early-stage Seed and Series A rounds in digital health, fintech, insurance, computer vision, and artificial intelligence startups. The firm previously operated under the temporary name, Ofek Ventures. It pursues startups that disrupt markets by using deep technology, creating new business models, and featuring entrepreneurial teams. 10D makes $1 million to $5 million in initial investments and follow-on investments of up to $10 million. Its portfolio companies include Seebo, the developer of artificial intelligence technologies for industrial plants; StuffThatWorks, a creator of a new healthcare database based on crowdsourcing; DayTwo, a provider of customized nutritional guidelines based on the gut microbiome for the purpose of lowering blood sugar levels; and additional investments. It was led by Yahal Zilka, Rotem Eldar, and Itay Rand in Tel Aviv, Israel.
Exodigo is a non-intrusive subsurface imaging platform that provides a digital geolocated 3D map of buried assets. The company utilizes a combination of multi-sensor fusion and artificial intelligence to dramatically improve accuracy and time to map while reducing damages and costs associated with unnecessary excavation. It also helps transportation, energy, utility, and construction leaders to design, dig, and build by providing accurate subsurface intelligence to derisk the underground.
Obligo rids both landlords and renters from the burden of security deposits and makes the move-in process as simple as checking into a hotel. Owners and managers use Obligo to simplify their move-in process, comply with changing regulatory landscapes, and make their listings more appealing to renters. As the only non-insurance deposit alternative, Obligo’s credit-based model keeps landlords secure and renters accountable by combining Open Banking technology and AI-based underwriting.
Medorion's SaaS solution enables healthcare organizations to create, manage, and measure highly personalized communication plans using Behavioral Science best practices and insights derived from clinical parameters in claims data. The solution transforms what is traditionally a cumbersome point solution-based process into intuitive and straightforward actions that allow Health Plans to personalize, streamline, and optimize their communication plans.
Juno Journey provides a platform to accompany, advise and lead employees of businesses through a process of personal growth. Dor Nachshoni founded it in 2017, with its headquarters in Herzliya in Israel.
Clair Labs' unique contact-free sensing solution extracts a wide range of physiological and behavioral markers. Their AI engine uses those markers to analyze critical health-related parameters during sleep and provide unprecedented visibility on our sleeping architecture, quality, and habits. Founded by former designers and researchers from Apple, Clair Labs is dedicated to helping people live happier, healthier lives by making high-quality sleep healthcare more accessible than ever.
DayTwo is a precision nutrition company that uses food as medicine to enable a path to remission for metabolic diseases including diabetes, prediabetes, clinical obesity, and NAFLD. DayTwo's groundbreaking scientific discovery, published in CELL (2015) and JAMA (2019) determined that people respond differently to the same food, thus knowing what food “works” for each person is crucial to an effective care plan. DayTwo uses gut microbiome sequencing (stool sample, akin to Cologuard) to create Food Prescriptions™ for each patient which balance blood sugar levels, improve energy, manage hunger, and help members lose weight. DayTwo virtual care solution is delivered through Certified Diabetes Care and Education Specialists and Registered Dietitians using a digital app to track progress and communicate with members.
Seebo helps customers unlock the full potential of their production lines. Seebo Process-Based Artificial Intelligence empowers manufacturing teams to achieve global process optimization across multiple, conflicting objectives – from improving quality, throughput, and yield, to reducing waste and scrap, cutting energy costs, and lowering emissions.
Acumen is an engineering intelligence platform that enables engineering teams to deliver software on time. The platform uses artificial intelligence to stitch together and interpret fragmented, incomplete data from across engineering tools. Acumen then mines through the data to unlock patterns and identify team-level blockers and risks. The result is a crystal-clear picture of what's going on day-to-day and how to unblock the team. For teams, this means fewer fire drills, less "work about work," and greater productivity.
Obligo rids both landlords and renters from the burden of security deposits and makes the move-in process as simple as checking into a hotel. Owners and managers use Obligo to simplify their move-in process, comply with changing regulatory landscapes, and make their listings more appealing to renters. As the only non-insurance deposit alternative, Obligo’s credit-based model keeps landlords secure and renters accountable by combining Open Banking technology and AI-based underwriting.
Stuff That Works develops a statistics engine that analyzes data and turns it into general and personalized insights. The community discusses insights and runs the ongoing research roadmap. It only takes a few people completing the survey to generate useful insights. The more people join, the deeper, and more personalized the insights. Stuff That Works was founded in 2018 and is headquartered in Israel.
Seebo helps customers unlock the full potential of their production lines. Seebo Process-Based Artificial Intelligence empowers manufacturing teams to achieve global process optimization across multiple, conflicting objectives – from improving quality, throughput, and yield, to reducing waste and scrap, cutting energy costs, and lowering emissions.
DayTwo is a precision nutrition company that uses food as medicine to enable a path to remission for metabolic diseases including diabetes, prediabetes, clinical obesity, and NAFLD. DayTwo's groundbreaking scientific discovery, published in CELL (2015) and JAMA (2019) determined that people respond differently to the same food, thus knowing what food “works” for each person is crucial to an effective care plan. DayTwo uses gut microbiome sequencing (stool sample, akin to Cologuard) to create Food Prescriptions™ for each patient which balance blood sugar levels, improve energy, manage hunger, and help members lose weight. DayTwo virtual care solution is delivered through Certified Diabetes Care and Education Specialists and Registered Dietitians using a digital app to track progress and communicate with members.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.